组织碎裂术治疗子宫平滑肌瘤:离体子宫肌瘤的可行性研究
研究在16例离体人子宫肌瘤样本上评估组织碎裂术(一种非侵入性非热聚焦超声消融方法)的可行性,使用700 kHz临床换能器多周期脉冲和500 kHz原型换能器单周期脉冲,超声实时监测,组织学定量消融效果;单周期脉冲在2000、4000、10000脉冲/点时分别出现早期凝固性坏死、近完全消融和完全组织破坏,多周期脉冲仅见弥漫空化而细胞消融改变轻微;作者认为组织碎裂术在特定脉冲参数下能够消融肌瘤,值得进一步研究。
要点
- 单周期组织碎裂术在10000脉冲/点可实现离体子宫肌瘤完全组织破坏。
- 单周期4000脉冲/点见近完全消融,2000脉冲/点见早期凝固性坏死。
- 多周期2000脉冲/点仅见弥漫空化,细胞消融改变轻微。
核心结论
- 组织碎裂术在特定脉冲参数下能够消融子宫肌瘤,值得进一步研究作为治疗平滑肌瘤的改进非侵入性消融方法。
研究设计与样本
- 离体实验研究,人子宫肌瘤样本n=16,取自Carilion Memorial Hospital子宫切除术或子宫肌瘤剔除术后;使用700 kHz临床换能器施加多周期组织碎裂术脉冲,原型500 kHz换能器施加单周期组织碎裂术脉冲;超声成像实时监测治疗,治疗后用苏木精-伊红和Masson三色染色组织学定量消融。
关键影像表现/征象
- 多周期组织碎裂术在靶向肌瘤中产生弥漫空化。
- 单周期脉冲产生边界清晰的泡云。
诊断标准与关键数值
- 多周期2000脉冲/点治疗后细胞消融改变轻微。
- 单周期2000脉冲/点组织学见早期凝固性坏死。
- 单周期4000脉冲/点见近完全消融。
- 单周期10000脉冲/点见完全组织破坏。
临床应用与阅片要点
- 作者认为组织碎裂术在特定脉冲参数下能够消融肌瘤,值得进一步研究作为改进的非侵入性消融方法。
局限性
- 原文结论指出值得进一步研究(warrants further investigation)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Uterine fibroids (leiomyomas), the most common benign tumors in women of reproductive age, are a frequent cause of abnormal vaginal bleeding and other reproductive complaints among women. This study investigates the feasibility of using histotripsy, a non-invasive, non-thermal focused ultrasound ablation method, to ablate uterine fibroids. Human fibroid samples (n = 16) were harvested after hysterectomy or myomectomy procedures at Carilion Memorial Hospital. Histotripsy was applied to ex vivo fibroids in two sets of experiments using a 700-kHz clinical transducer to apply multicycle histotripsy pulses and a prototype 500-kHz transducer to apply single-cycle histotripsy pulses. Ultrasound imaging was used for real-time treatment monitoring, and post-treatment ablation was quantified histologically using hematoxylin and eosin and Masson trichrome stains. Results revealed that multicycle histotripsy generated diffuse cavitation in targeted fibroids, with minimal cellular ablative changes after treatment with 2000 pulses/point. Single-cycle pulsing generated well-confined bubble clouds with evidence of early coagulative necrosis on histological assessment in samples treated with 2000 pulses/point, near-complete ablation in samples treated with 4000 pulses/point and complete tissue destruction in samples treated with 10,000 pulses/point. This study illustrates that histotripsy is capable of fibroid ablation under certain pulsing parameters and warrants further investigation as an improved non-invasive ablation method for the treatment of leiomyomas.
引用
- Simon, Robinson, Anzivino, et al. Histotripsy for the Treatment of Uterine Leiomyomas: A Feasibility Study in Ex Vivo Uterine Fibroids. Ultrasound Med Biol. 2022. PMID: 35641394. doi:10.1016/j.ultrasmedbio.2022.04.214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。